Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
A landmark multi-country clinical trial has shown that a structured, sustainable approach to infection prevention and treatment can save women's lives, cutting severe maternal infections and deaths by ...
Can you chip in? As an independent nonprofit, the Internet Archive is fighting for universal access to quality information. We build and maintain all our own systems, but we don’t charge for access, ...
PERTH, Nov 4 (Reuters) - Australia will offer at least three hours of free solar power every day to households including those without solar panels under an energy-saving programme that is expected to ...
Our treatment facility provides a nurturing and structured community where adolescents learn essential emotional and life skills. Through a collaborative, multi-disciplinary approach, we help teens ...
Elevate your grant writing to craft compelling proposals and secure research funding. The Grant Writing Intensive (GRIT) program is a year-long practicum designed to empower faculty from the CCTS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback